These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10171169)

  • 1. Implantable cardioverter-defibrillators: the second decade.
    Fazio GP; Veltri EP
    Curr Opin Cardiol; 1991 Feb; 6(1):72-7. PubMed ID: 10171169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitachycardia devices: realities and promises.
    Klein LS; Miles WM; Zipes DP
    J Am Coll Cardiol; 1991 Nov; 18(5):1349-62. PubMed ID: 1918713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators.
    Groh WJ; Foreman LD; Zipes DP
    Am Fam Physician; 1998 Jan; 57(2):297-307, 310-2. PubMed ID: 9456993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current role of the automatic implantable cardioverter-defibrillator in the treatment of life-threatening ventricular arrhythmias.
    Kay GN; Plumb VJ; Dailey SM; Epstein AE
    Am J Med; 1990 Jan; 88(1N):25N-34N. PubMed ID: 2195882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Implantable defibrillators. Clinical experience].
    Mirowski M; Mower MM; Veltri EP; Juanteguy JM
    Ann Cardiol Angeiol (Paris); 1986 Dec; 35(10):589-95. PubMed ID: 3827149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic and clinical progress in implantable devices for control of ventricular tachyarrhythmias and prevention of sudden death.
    Winters SL; Deshmukh P; Camunas JL; Estioko MR; Gomes JA
    Curr Opin Cardiol; 1990 Aug; 5(4):496-501. PubMed ID: 10171139
    [No Abstract]   [Full Text] [Related]  

  • 8. Current application of implantable cardioverter-defibrillators in the management of malignant ventricular tachyarrhythmias.
    Saksena S
    Cardiology; 1990; 77(3):181-94. PubMed ID: 2272056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent clinical experience with the automatic implantable cardioverter-defibrillator.
    Mirowski M; Mower MM; Veltri EP; Juanteguy JM; Reid PR
    Cardiol Clin; 1985 Nov; 3(4):623-30. PubMed ID: 3910242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of malignant ventricular arrhythmias with implantable cardioverter-defibrillators: a reality but still with numerous questions].
    Arenal A; Almendral J; Albertos J
    Rev Esp Cardiol; 1992 Jan; 45(1):1-4. PubMed ID: 1549756
    [No Abstract]   [Full Text] [Related]  

  • 11. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac implantable electronic device and vascular access: Strategies to overcome problems.
    Kusztal M; Nowak K
    J Vasc Access; 2018 Nov; 19(6):521-527. PubMed ID: 29552930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of malignant ventricular arrhythmias using antitachycardia devices.
    McCowan RJ; Sampath R; Lee KC; Rashid H; Cafoncelli AR; Khan ZM; Malik FS; Chapman JL; Figueroa E; Freund PE
    W V Med J; 1991 Sep; 87(9):395-9. PubMed ID: 1949755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter defibrillator: possible hazards of electromagnetic interference.
    Schmitt C; Brachmann J; Waldecker B; Navarrete L; Beyer T; Pfeifer A; Kübler W
    Pacing Clin Electrophysiol; 1991 Jun; 14(6):982-4. PubMed ID: 1715073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.
    Boriani G; Merino J; Wright DJ; Gadler F; Schaer B; Landolina M
    Europace; 2018 Dec; 20(12):1882-1897. PubMed ID: 29757390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitachycardia pacing with cardioverter-defibrillator backup for malignant ventricular dysrhythmias.
    Thomson JE; Olash J
    J Cardiovasc Nurs; 1990 Feb; 4(2):33-43. PubMed ID: 2099749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular implantable electronic devices in athletes.
    Do R; Patton KK
    Cardiovasc Ther; 2010 Oct; 28(5):327-36. PubMed ID: 20553287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
    Tan VH; Wilton SB; Kuriachan V; Sumner GL; Exner DV
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):164-70. PubMed ID: 24446023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.